The Demand for Nanoparticles in Drug Formulation is Rising

11.02.2022

Demand for nanoparticles in the biopharmaceutical industry is on the rise. Production of these tiny particles, which can protect and deliver medicines and vaccines where they need to go in the body, has been increasing since 1989.

Collaborating with an experienced partner, such as a CDMO, could prove to be invaluable in developing nano-based systems.

Read more about the benefits and challenges of nanoparticle production.

Emergent CDMO

Thought Leadership Nanoparticles

06.28.2023

4 Steps for a Smooth Tech Transfer When Working with a CDMO

In our recent article with BioPharma Dive, Emergent's Shelly Buhay, Director of MS&T and Dan Perrin, Director of Manufacturing...

01.13.2022

A look inside our Center of Excellence for Development Services

From analytical development to drug substance and drug product process development and scale-up, we can help advance your...

11.30.2020

Factoring Stability in the Biologic Drug Mix

Jee Look, senior director of drug product development for Emergent BioSolutions recently contributed to an article in ...